A two-center case series explores the addition of finerenone to existing treatments for patients with Alport syndrome. This study highlights potential therapeutic strategies for managing this rare genetic condition.
finerenone added to renin angiotensin system and sodium glucose cotransporter 2 inhibition in patients with alport syndrome a two center case series
Original title: “Finerenone Added to Renin-Angiotensin System- and Sodium-Glucose Cotransporter 2 Inhibition in Patients with Alport Syndrome: A Two-Center Case Series.”